These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7035868)

  • 1. Muramyl peptides. Chemical structure, biological activity and mechanism of action.
    Adam A; Petit JF; Lefrancier P; Lederer E
    Mol Cell Biochem; 1981 Dec; 41():27-47. PubMed ID: 7035868
    [No Abstract]   [Full Text] [Related]  

  • 2. Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.
    Parant M; Parant F; Chedid L; Yapo A; Petit JF; Lederer E
    Int J Immunopharmacol; 1979; 1(1):35-41. PubMed ID: 551094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
    Chedid L; Carelli C; Audibert F
    J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel muramyl peptide derivative stimulates tumoricidal activity of macrophages and antibody production by B cells.
    Tenu JP; Adam A; Souvannavong V; Barratt G; Yapo A; Petit JF; Level M; Clemance M; Douglas K
    FEBS Lett; 1987 Aug; 220(1):93-7. PubMed ID: 3497058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of muramyl peptides for the enhancement of synthetic vaccines.
    Chedid L; Audibert F; Jolivet M
    Dev Biol Stand; 1986; 63():133-40. PubMed ID: 3527818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An adjuvant formulation based on N-acetylglucosaminyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with dimethyldioctadecylammonium chloride and zinc-L-proline complex as synergists.
    Grubhofer N
    Immunol Lett; 1995 Jan; 44(1):19-24. PubMed ID: 7721338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
    Chedid LA; Parant MA; Audibert FM; Riveau GJ; Parant FJ; Lederer E; Choay JP; Lefrancier PL
    Infect Immun; 1982 Feb; 35(2):417-24. PubMed ID: 7035362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freund's adjuvant, NOD2 and mycobacteria.
    Behr MA; Divangahi M
    Curr Opin Microbiol; 2015 Feb; 23():126-32. PubMed ID: 25483349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fundamental studies to use the adjuvant activity of 6-o-acylmuramyldipeptides to potentiate cell and humoral immune responses for practical purposes].
    Tsujimoto M
    J Osaka Univ Dent Sch; 1981 Jun; 26(1):63-83. PubMed ID: 6945426
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.
    Chedid L; Audibert F; Johnson AG
    Prog Allergy; 1978; 25():63-105. PubMed ID: 362430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological properties of synthetic glycopeptides stimulating immunogenesis and nonspecific resistance].
    Dzheksenbaev OSh
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):13-8. PubMed ID: 7032159
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic influences on the adjuvanticity of muramyl dipeptide in vivo.
    Staruch MJ; Wood DD
    J Immunol; 1982 Jan; 128(1):155-60. PubMed ID: 6976368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental allergic encephalomyelitis induced by basic protein with synthetic adjuvant in comparison with Freund's complete adjuvant. Role of antibodies in correlation with the clinicopathological features.
    Mitsuzawa E; Yasuda T; Tamura N; Ohtani S
    J Neurol Sci; 1981 Oct; 52(1):133-45. PubMed ID: 6170738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
    Leclerc C; Audibert F; Chedid L
    Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Leclerc C; Juy D; Bourgeois E; Chedid L
    Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant.
    Dubé JY; McIntosh F; Zarruk JG; David S; Nigou J; Behr MA
    Sci Rep; 2020 Apr; 10(1):5874. PubMed ID: 32246076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
    Bomford R
    Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes containing muramyl tripeptide phosphatidylethanolamine (MTP-PE) are excellent adjuvants for induction of an immune response to protein and tumor antigens.
    Ullrich SE; Fidler IJ
    J Leukoc Biol; 1992 Nov; 52(5):489-94. PubMed ID: 1431559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.